Cargando…
Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia: Involvement of Necrotic and Apoptotic Cell Death
Ischemic stroke is the leading cause of disability and the second leading cause of death worldwide. However, current therapeutic strategies are scarce and of limited efficacy. The abundance of information available on the molecular pathophysiology of ischemic stroke has sparked considerable interest...
Autores principales: | Chamorro, Beatriz, Izquierdo-Bermejo, Sara, Martín-de-Saavedra, María Dolores, López-Muñoz, Francisco, Chioua, Mourad, Marco-Contelles, José, Oset-Gasque, María Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376237/ https://www.ncbi.nlm.nih.gov/pubmed/37507904 http://dx.doi.org/10.3390/antiox12071364 |
Ejemplares similares
-
Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic Stroke
por: Martínez-Alonso, Emma, et al.
Publicado: (2020) -
Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke
por: Martínez-Alonso, Emma, et al.
Publicado: (2022) -
Neuroprotective and antioxidant properties of new quinolylnitrones in in vitro and in vivo cerebral ischemia models
por: Chamorro, Beatriz, et al.
Publicado: (2023) -
Homo-Tris-Nitrones Derived from α-Phenyl-N-tert-butylnitrone: Synthesis, Neuroprotection and Antioxidant Properties
por: Diez-Iriepa, Daniel, et al.
Publicado: (2020) -
Melatonin and Nitrones As Potential Therapeutic Agents for Stroke
por: Romero, Alejandro, et al.
Publicado: (2016)